Company Overview of Amphion Innovations Plc
Amphion Innovations plc is a venture capital firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceuticals...
125 Park Avenue
New York, NY 10017
Founded in 1984
Key Executives for Amphion Innovations Plc
CEO & Executive Director
Total Annual Compensation: 353.8K GBP
President, CFO & Executive Director
Total Annual Compensation: 303.5K GBP
Compensation as of Fiscal Year 2016.
Amphion Innovations Plc Key Developments
Amphion Innovations plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017
Sep 29 17
Amphion Innovations Plc announced unaudited consolidated earnings results for the six months ended June 30, 2017. For the period, the company reported revenue was $15,300 against $60,000 a year ago. Operating loss was $1,599,817 against $1,505,488 a year ago. Profit before tax was $1,684,854 against $320,027 a year ago. Profit for the period was $1,684,854 against $320,027 a year ago. Basic and diluted per share was $0.01 against basic and diluted per share of $0 a year ago. Net cash used in operating activities was $1,379,908 against $1,714,415 a year ago.
Motif Bio plc Announces Amendment to Amphion Innovations Plc Consultancy Agreement
Jul 18 17
Motif Bio plc announced that it has amended the terms of its consultancy agreement with Amphion Innovations plc. On April 1, 2015, the Group entered into a consultancy agreement with Amphion Innovations plc for the services of Robert Bertoldi, an employee of Amphion Innovations plc. The consideration for his services was $5,000 per month. On November 1, 2015, the consideration was increased to $180,000 per annum. On July 1, 2016, the consideration decreased to $75,000. Motif has now increased the consideration to $125,000. The amendment to the consultancy agreement constitutes a related party transaction under AIM Rule 13 of the AIM Rules for Companies as Amphion Innovations plc is a substantial shareholder of Motif.
Amphion Innovations Plc Reports Audited Consolidated and Company Earnings Results for the Year Ended December 31, 2016
Jun 28 17
Amphion Innovations Plc reported audited consolidated and company earnings results for the year ended December 31, 2016. For the year, on consolidated basis, the company reported revenue of USD 139,633 against USD 519,855 a year ago. Operating loss was USD 3,334,412 against USD 4,160,357 a year ago. Loss before tax was USD 16,841,999 against profit of USD 5,943,699 a year ago. Loss for the year was USD 16,843,234 against profit of USD 5,941,799 a year ago. Loss of USD 0.09 per basic and diluted per share against profit of USD 0.02 per diluted share a year ago. Net cash used in operating activities was USD 3,680,170 against USD 2,829,866 a year ago. Purchases of investments were USD 395,015 against USD 402,015 a year ago.
On company basis, the company reported operating loss was USD 1,952,662 against USD 2,068,530 a year ago. Loss before tax was USD 12,697,790 against profit of USD 5,219,730 a year ago. Loss for the year was USD 12,697,790 against profit of USD 5,219,730 a year ago. Net cash used in operating activities was USD 3,675,782 against USD 2,900,764 a year ago. Purchases of investments were USD 395,015 against USD 402,015 a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|